全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 170367-69-8 | (R)-3-Boc-aminobutylamine;(R)-3-N-Boc-butane-1,3-diamine | C9H20N2O2 |
| 170384-29-9 | (2-Oxopropyl)carbamic acid tert-butyl ester | C8H15NO3 |
| 170434-11-4 | 4-Bromo-2-hydroxybenzyl alcohol | C7H7BrO2 |
| 170449-18-0 | N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine hydrochloride;6,7-Dimethoxy-4-[N-(3-chlorophenyl)amino]quinazoline hydrochloride | C16H14ClN3O2.HCl |
| 170487-38-4 | Methyl 4-oxazolecarboxylate | C5H5NO3 |
| 170487-40-8 | Methyl 1H-indazole-6-carboxylate;1H-Indazole-6-carboxylic acid methyl ester | C9H8N2O2 |
| 170491-63-1 | tert-Butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate;2-Hydroxymethylpyrrolidine-1-carboxylic acid tert-butyl ester; N-(tert-Butoxycarbonyl)pyrrolidine-2-methanol; N-Boc-2-hydroxymethylpyrrolidine | C10H19NO3 |
| 170492-47-4 | 1-Hydroxy-6-methylsulfonylindole | C9H9NO3S |
| 170564-98-4 | (R)-3-Amino-3-phenylpropan-1-ol;(R)-1-Phenyl-3-propanolamine | C9H13NO |
| 170569-88-7 | Mavacoxib;4-[5-(4-Fluorophenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide; PHA 739521; Trocoxil | C16H11F4N3O2S |
| 170570-01-1 | 4-[5-(3-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide | C17H14F3N3O2S |
| 170572-38-0 | 2,5,8,11,14,17,20-Heptaoxadocosan-22-amine | C15H33NO7 |
| 170572-47-1 | 3,5-Difluoro-4-hydroxybenzoic acid methyl ester | C8H6F2O3 |
| 170572-48-2 | 1,3-Difluoro-2-methyl-5-nitrobenzene | C7H5F2NO2 |
| 170572-49-3 | 3-Fluoro-4-methylbenzonitrile | C8H6FN |
| 170572-50-6 | 3,5-Difluoro-4-methylbenzonitrile | C8H5F2N |
| 170572-51-7 | 5-Chloro-1,3-difluoro-2-methoxybenzene | C7H5ClF2O |
| 170621-86-0 | 4-Chloro-3-methoxypyridine-2-carboxylic acid | C7H6ClNO3 |
| 170632-47-0 | Lificiguat;1-Benzyl-3-(5-hydroxymethylfur-2-yl)indazole; YC 1; YC 1 (pharmaceutical) | C19H16N2O2 |
| 170642-27-0 | Fmoc-D-2-aminobutyric acid | C19H19NO4 |
| 170642-28-1 | (R)-N-Fmoc-Allylglycine;Fmoc-D-2-allylglycine; (R)-N-(9-Fluorenylmethoxycarbonyl)-2-amino-4-pentenoic acid; Fmoc-allyl-Gly-OH | C20H19NO4 |
| 170642-29-2 | Fmoc-D-Cyclopropylalanine | C21H21NO4 |
| 170642-31-6 | (R)-2-Amino-3-(2-methoxyphenyl)propanoic acid | C10H13NO3 |
| 170643-02-4 | O-(tert-Butyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-allothreonine | C23H27NO5 |
| 170655-44-4 | 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide | C4H5ClF3NO |
| 170681-91-1 | 5-Bromo-7-methylbenzofuran | C9H7BrO |
| 170701-87-8 | Aziridine-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester | C12H13NO4 |
| 170713-75-4 | Orphanin FQ (pig);Human nociceptin; Nociceptin (human); Nociceptin 1-17; Orphanin FQ (human); Orphanin FQ (rat) | C79H129N27O22 |
| 170727-02-3 | 3-Bromothiophene-2-sulfonyl chloride | C4H2BrClO2S2 |
| 170727-59-0 | Isoloratadine;Loratadine EP Impurity E;ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylate | C22H23ClN2O2 |
| 170729-76-7 | 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-phenyl-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one | C23H22F6N4O3 |
| 170729-80-3 | Aprepitant;5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one | C23H21F7N4O3 |
| 170730-06-0 | 7-Acetyl-2,3-dihydrobenzofuran | C10H10O2 |
| 170737-46-9 | 6-Bromo-2-naphthaldehyde | C11H7BrO |
| 170737-53-8 | 1-[(Phenylmethoxy)carbonyl]-4-piperidineacetic acid methyl ester | C16H21NO4 |
| 170737-93-6 | 2-Chloro-4-methoxybenzeneacetonitrile | C9H8ClNO |
| 170737-95-8 | 4-Chloro-2-methoxybenzeneacetic acid;(4-Chloro-2-methoxyphenyl)acetic acid | C9H9ClO3 |
| 170749-59-4 | 3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester acetate | C19H21N3O2.C2H4O2 |
| 170787-99-2 | Efaproxiral sodium;Sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoate | C20H22NNaO4 |
| 170791-09-0 | Trityl candesartan cilexetil | C52H48N6O6 |
| 170793-00-7 | 3-Fluoro-4-chlorophenylmagnesium bromide | C6H3BrClFMg |
| 170809-51-5 | Astressin;(4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(3S,6S,9S,18S)-18-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]carbamoyl]-3-(1H-imidazol-4-ylmethyl)-6-methyl-2,5,8,12-tetraoxo-1,4,7,13-tetrazacyclooctadec-9-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-carboxybutanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-oxopentanoic acid | C161H269N49O42 |
| 170843-43-3 | Ethyl 3-methylpiperidine-3-carboxylate;3-Methyl-3-piperidinecarboxylic acid ethyl ester | C9H17NO2 |
| 170844-49-2 | Ethyl 1-Boc-3-pyrrolidinecarboxylate;Pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester | C12H21NO4 |
| 170848-34-7 | Methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-iodopropanoate;Boc-3-iodo-D-Ala-OMe | C9H16INO4 |
| 170851-70-4 | Ipamorelin;(2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide | C38H49N9O5 |
| 170856-84-5 | (1S)-3,4-Dihydro-1H-2-benzopyran-1-acetic acid | C11H12O3 |
| 170858-33-0 | Sonepiprazole;PNU 101387 | C21H27N3O3S |
| 170863-34-0 | (2R,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide | C13H14F2N4OS |
| 170886-13-2 | 2-Trifluoromethylpyridin-4-ol;4-Hydroxy-2-trifluoromethylpyridine | C6H4F3NO |